References
- Leoni D, Rello J. Cardiac arrest among patients with infections: causes, clinical practice and research implications. Clin Microbiol Infect. 2016;23:730–735.
- Lagu T, Rothberg MB, Shieh MS, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012;40:754–761.
- Morgan RW, Fitzgerald JC, Weiss SL, et al. Sepsis-associated in-hospital cardiac arrest: epidemiology, pathophysiology, and potential therapies. J Crit Care. 2017;40:128–135.
- Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10:701–706.
- Opal SM. Endotoxins and other sepsis triggers. Contrib Nephrol. 2010;167:14–24.
- Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest. 2006;86:9–22.
- Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res. 2010;339:269–280.
- Moser M, Legate KR, Zent R, et al. The tail of integrins, talin, and kindlins. Science. 2009;324:895–899.
- Wu MH, Ustinova E, Granger HJ. Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. J Physiol. 2001;532:785–791.
- Su G, Atakilit A, Li JT, et al. Absence of integrin alphavbeta3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. Am J Respir Crit Care Med. 2012;185:58–66.
- Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother. 2010;1:94–99.
- Nishida M, Carley WW, Gerritsen ME, et al. Isolation and characterization of human and rat cardiac microvascular endothelial cells. Am J Physiol. 1993;264:H639–652.
- Lennon FE, Singleton PA. Hyaluronan regulation of vascular integrity. Am J Cardiovasc Dis. 2011;1:200–213.
- Castanares-Zapatero D, Bouleti C, Sommereyns C, et al. Connection between cardiac vascular permeability, myocardial edema, and inflammation during sepsis: role of the alpha1AMP-activated protein kinase isoform. Crit Care Med. 2013;41:e411–422.
- Bar-Or D. The filamentous actin cytoskeleton organization and the endothelial cell barrier. Crit Care Med. 2013;41:686–687.
- Altman SM, Dixit N, Simon SI. Detection of bidirectional signaling during integrin activation and neutrophil adhesion. Methods Mol Biol. 2014;1124:235–248.
- Morse EM, Brahme NN, Calderwood DA. Integrin cytoplasmic tail interactions. Biochemistry. 2014;53:810–820.
- Check J, Byrd CL, Menio J, et al. Src kinase participates in LPS-induced activation of NADPH oxidase. Mol Immunol. 2010;47:756–762.
- Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279–367.
- Hu G, Minshall RD. Regulation of transendothelial permeability by Src kinase. Microvasc Res. 2009;77:21–25.
- Kim MP, Park SI, Kopetz S, et al. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis. Cell Tissue Res. 2009;335:249–259.
- Zang G, Christoffersson G, Tian G, et al. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells. Cell Signal. 2013;25:85–92.
- Schlegel N, Waschke J. cAMP with other signaling cues converges on Rac1 to stabilize the endothelial barrier- a signaling pathway compromised in inflammation. Cell Tissue Res. 2014;355:587–596.
- Komarova YA, Kruse K, Mehta D, et al. Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability. Circ Res. 2017;120:179–206.